Journal profile · Pathology
Alzheimer Disease & Associated Disorders
ISSN 0893-0341 · eISSN 1546-4156 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Quarterly · Founded 1987
Alzheimer Disease & Associated Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.59; JCR Q3 (journal website); hybrid open access; median 70 days to acceptance (14 articles, last 24 months); community-reported acceptance: fairly easy; 56 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Alzheimer Disease & Associated Disorders is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Health Systems, Economic Evaluations, Quality of Life, together about 55.9% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Alzheimer Disease & Associated Disorders is a peer-reviewed, multidisciplinary journal directed to an audience of clinicians and researchers, with primary emphasis on Alzheimer disease and associated disorders. The journal publishes original articles emphasizing research in humans including epidemiologic studies, clinical trials and experimental studies, studies of diagnosis and biomarkers, as well as research on the health of persons with dementia and their caregivers. The scientific portion of the journal is augmented by reviews of the current literature, concepts, conjectures, and hypotheses in dementia, brief reports, and letters to the editor.
Source: LetPub
Research area (LetPub): Pathology
Editor-in-chief José Luchsinger-StuartPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dementia and Cognitive Impairment ResearchMedicine33.5%
- Alzheimer's disease research and treatmentsMedicine18.4%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4%
- Cholinesterase and Neurodegenerative DiseasesMedicine3.8%
- Geriatric Care and Nursing HomesHealth Professions3.2%
- Neurological Disease Mechanisms and TreatmentsNeuroscience3.2%
- Neurological Disorders and TreatmentsNeuroscience2.8%
- Parkinson's Disease Mechanisms and TreatmentsMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · CLINICAL NEUROLOGY · rank 226/296
- JCR Q3 · PATHOLOGY · rank 57/89
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.59LetPub ·
- Impact factor (publisher)
- 1.6Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- SJR 2026-06
- 0.49LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 88LetPub ·
- h-index
- 131OpenAlex ·
- i10-index
- 1,568OpenAlex ·
- 2-year mean citedness
- 1.54OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 14.53%LetPub ·
Volume
- Articles per year
- 54LetPub ·
Articles by year OpenAlex count · 2,962 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 41 | 7 | 3 |
| 2025 | 56 | 19 | 70 |
| 2024 | 57 | 34 | 164 |
| 2023 | 59 | 39 | 310 |
| 2022 | 54 | 28 | 380 |
| 2021 | 59 | 27 | 574 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
70 daysMedian, submission to acceptance · P25–P75 45 days – 90 days
- Acceptance to online
- median 31 days (1 articles)
- Submission to online
- median 276 days
- Sample
- 14 articles with submission and acceptance dates (22 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1987
- ISSN
- 0893-0341
- Electronic ISSN
- 1546-4156
- Latest issue on the website
- Volume 40, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Alzheimer Disease & Associated Disorders
What CAS zone is Alzheimer Disease & Associated Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Alzheimer Disease & Associated Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Alzheimer Disease & Associated Disorders?
The latest impact factor listed by LetPub is 1.59; CiteScore 2.7, h-index 131.
How long does peer review take at Alzheimer Disease & Associated Disorders?
Based on the dates recorded on 14 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 70 days (interquartile range 45–90 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Alzheimer Disease & Associated Disorders in?
The journal's website gives JCR Q3; by category, CLINICAL NEUROLOGY Q4 (226/296), PATHOLOGY Q3 (57/89). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Alzheimer Disease & Associated Disorders?
According to LetPub and DOAJ records, Alzheimer Disease & Associated Disorders is indexed in SCIE and Scopus.
Is Alzheimer Disease & Associated Disorders open access, and what is the APC?
Alzheimer Disease & Associated Disorders is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .